Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Profile

Profile of Benjamin Cravatt

Jennifer Viegas
PNAS February 2, 2016 113 (5) 1109-1111; first published January 25, 2016; https://doi.org/10.1073/pnas.1525099113
Jennifer Viegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

See related content:

  • DAGL inhibitors alter brain lipid networks
    - Dec 14, 2015
  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Bridging the fields of chemistry and biology, Benjamin Cravatt and his research group have developed and applied technologies to discover biochemical pathways in mammalian biology and disease. Cravatt, who was elected to the National Academy of Sciences in 2014 and is chair of the Department of Chemical Physiology at The Scripps Research Institute, pioneered an approach to identify protein classes based on their activity. Since the introduction of the approach in 1999, Cravatt’s group has used this and related chemical proteomic technologies to conduct global analyses of protein activities and to elucidate the functions of several enzymes, including those linked to human cancers, neurological disorders, and the endocannabinoid system, which consists of lipid transmitters involved in appetite, pain sensation, mood, memory, and other physiological processes.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Benjamin Cravatt. Image courtesy of TSRI BioMedical Graphics.

Encouraged to Think About Biology

From the outset, Cravatt was inspired to think about biology by his dentist father and dental hygienist mother. He also credits his high school mathematics teachers for nurturing his interest in the quantitative sciences. “These individuals made subjects like calculus interesting and relatable to the young mind,” Cravatt says. “They also challenged me to extend beyond my comfort zone in my education, which helped me gain confidence in my abilities.”

In 1988, Cravatt entered Stanford University with the aim of studying medicine. That goal began to change, however, when he studied under chemist John Griffin, now the chief scientific officer of the biotech company Numerate. Cravatt explains, “I had a great undergraduate research experience in John Griffin’s lab, and this certainly set me on a trajectory to pursue research at the interface of biology and chemistry.” Cravatt graduated in 1992 with bachelor’s degrees in biological sciences and history. He then earned his doctorate in macromolecular and cellular structure and chemistry at The Scripps Research Institute in 1996. That same year, he became an assistant professor. Cravatt says, “I started at Scripps, and never looked back.”

In 1996 Cravatt and his colleagues authored an influential paper concerning a key enzyme, FAAH, which is involved in the endocannabinoid system (1). Cravatt says he spent much of the last two years of graduate school in a laboratory cold room purifying the FAAH enzyme to sufficient homogeneity for its molecular characterization. “There were many days where I doubted whether I would succeed in the project, but the hard work ultimately paid off,” he says. “FAAH became the first of several important enzymes that have been discovered to regulate endocannabinoid metabolism and signaling in the mammalian brain, some of which are potential drug targets to treat human disease.”

Foundations of Chemical Proteomics

The work of Cravatt and his colleagues on the endocannabinoid system led to interest in the then-nascent field of chemical proteomics, a multidisciplinary science that aims to develop and apply chemical tools to annotate the functions of proteins like FAAH within their native biological environment. Cravatt credits two major technological advances for laying the foundations of the field: DNA sequencing, which provided a near-complete molecular parts-list encoded by an organism’s genome, and the introduction of mass spectrometry instruments with remarkable accuracy and resolution. Cravatt also notes the achievements of his colleague John Yates, who developed a search algorithm called SEQUEST, which allows in-depth analysis of entire sets of proteins in a mass spectrometry-based proteomics experiment.

The chemical proteomic technology Activity-Based Protein Profiling (ABPP), pioneered by Cravatt and colleagues (2), employs chemical probes to directly measure enzyme function. For example, a fluorescent label may be used to tag enzymes with certain chemical properties, allowing researchers to survey all active enzymes in a cell at once. ABPP thus enables enrichment and identification of large classes of mechanistically related proteins directly from native biological systems. “The ABPP method has grown to be quite useful for protein and inhibitor discovery,” Cravatt says. In 2010, for example, Cravatt and colleagues used ABPP to investigate cysteines, which are amino acids that represent one of the 20 building blocks of protein (3). The researchers discovered that the intrinsic reactivity of cysteine residues varies greatly across the proteome. They further determined that cysteines with high reactivity are much more likely to perform important functions in cells.

Cravatt’s team, again working with native biological systems, has also shown that untargeted mass spectrometry methods can be used to discover natural substrates for enzymes (4, 5). In the past, such research would have been more commonly conducted in artificially reconstituted test-tube settings. “I have always been interested in unbiased, data-driven approaches to research,” Cravatt says.

Applying ABPP to Human Genetic Disorders

ABPP has also provided functional insights into the burgeoning connections being made between human genome sequences and disease. Cravatt says, “Advances in DNA sequencing technologies are propelling us into an age where virtually all Mendelian genetic disorders [meaning rare diseases caused by a mutation in a single gene, such as sickle-cell anemia and cystic fibrosis] will be mapped to their causative mutational basis. However, many of these mutations occur in genes that code for proteins of uncharacterized function.”

To address the conundrum, Cravatt and his team have combined ABPP with metabolomics—the measurement and analysis of metabolites, such as sugars and fats—to study rare neurological disorders caused by mutations in poorly characterized enzymes (6, 7). The researchers were able to determine the biochemical functions of these enzymes in the brain, providing insights into disease mechanism and potential treatment strategies.

Such successful innovative research approaches have earned Cravatt several awards, including Technology Review’s TR100 Top 100 Young Innovators Award (2002), the Eli Lilly Award in Biological Chemistry, American Chemical Society (2004), the ASBMB-Merck Award (2014), and the Sato Memorial International Award, Pharmaceutical Society of Japan (2015). In 2009, Cravatt was granted a MERIT award from the National Cancer Institute in recognition of the important contributions that ABPP technologies have made to characterizing deregulated enzyme activities, as well as the drugs that target these enzymes, in cancer.

Extending ABPP to Metabolite-Binding Proteins

Cravatt and his team have more recently adapted their chemical proteomic methods to construct a global map of lipid-binding proteins and the drugs that interact with these proteins (8). To do so, they once again used ABPP, but in this case constructed chemical probes that resemble natural bioactive lipids conjugated to a photoreactive group to trap interacting proteins in cells upon exposure to light. The method provided a broad and deep portrait of lipid-binding proteins in human cells, and the resulting map not only shed light on the functions of lipid-binding proteins, but also helped profile the activities of drug compounds by revealing how they may interfere with lipid–protein binding events.

Endocannabinoid-Regulating Enzymes

Cravatt’s Inaugural Article (9) investigates the function of enzymes called diacylglycerol lipases (DAGLs), which regulate the production of endocannabinoids. Understanding the full spectrum of functions for DAGL-endocannabinoid pathways, however, requires selective inhibitors to perturb these pathways in cell and animal models. “Our findings with DAGL inhibitors revealed that these enzymes make key contributions to a much larger brain lipid network that includes not only endocannabinoids, but also eicosanoids and other signaling lipids,” Cravatt says. “Consequently, blocking DAGLs impairs neuroinflammatory processes in vivo, suggesting that inhibitors of these enzymes may be useful for treating neurological disorders that have a strong inflammatory underpinning, such as neurodegeneration and autoimmune disorders of the central nervous system.”

Although Cravatt’s work holds tremendous potential for the creation of novel, effective treatments for many diseases, his laboratory does not select proteins for investigation based on therapeutic interest per se, but rather based on their potential relevance to human biology and disease. “This may seem like a subtle distinction, but it is not. I believe that gaining a fundamental understanding of a protein’s function will, by default, lead thoughtful and creative scientists to potential therapeutic strategies for treating disorders connected to that protein.”

Cravatt also says that he is a firm believer that technological advances pave the way for leaps in scientific discovery and understanding. He says, “Our lab feels very fortunate to live in an era where the genetics of human disease is being illuminated with such precision and completeness, as this knowledge base becomes a major source for our prioritization of poorly characterized proteins for functional investigation.”

Footnotes

    • This is a Profile of a recently elected member of the National Academy of Sciences to accompany the member’s Inaugural Article on page 26 in issue 1 of volume 113.

    View Abstract

    References

    1. ↵
      1. Cravatt BF, et al.
      (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384(6604):83–87
      .
      OpenUrlCrossRefPubMed
    2. ↵
      1. Liu Y,
      2. Patricelli MP,
      3. Cravatt BF
      (1999) Activity-based protein profiling: The serine hydrolases. Proc Natl Acad Sci USA 96(26):14694–14699
      .
      OpenUrlAbstract/FREE Full Text
    3. ↵
      1. Weerapana E, et al.
      (2010) Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468(7325):790–795
      .
      OpenUrlCrossRefPubMed
    4. ↵
      1. Saghatelian A, et al.
      (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43(45):14332–14339
      .
      OpenUrlCrossRefPubMed
    5. ↵
      1. Dix MM,
      2. Simon GM,
      3. Cravatt BF
      (2008) Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134(4):679–691
      .
      OpenUrlCrossRefPubMed
    6. ↵
      1. Blankman JL,
      2. Long JZ,
      3. Trauger SA,
      4. Siuzdak G,
      5. Cravatt BF
      (2013) ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci USA 110(4):1500–1505
      .
      OpenUrlAbstract/FREE Full Text
    7. ↵
      1. Inloes JM, et al.
      (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase. Proc Natl Acad Sci USA 111(41):14924–14929
      .
      OpenUrlAbstract/FREE Full Text
    8. ↵
      1. Niphakis MJ, et al.
      (2015) A global map of lipid-binding proteins and their ligandability in cells. Cell 161(7):1668–1680
      .
      OpenUrlCrossRefPubMed
    9. ↵
      1. Ogasawara D, et al.
      (2016) Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proc Natl Acad Sci USA 113(1):26–33
      .
      OpenUrlAbstract/FREE Full Text
    PreviousNext
    Back to top
    Article Alerts
    Email Article

    Thank you for your interest in spreading the word on PNAS.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Profile of Benjamin Cravatt
    (Your Name) has sent you a message from PNAS
    (Your Name) thought you would like to see the PNAS web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Profile of Benjamin Cravatt
    Jennifer Viegas
    Proceedings of the National Academy of Sciences Feb 2016, 113 (5) 1109-1111; DOI: 10.1073/pnas.1525099113

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Request Permissions
    Share
    Profile of Benjamin Cravatt
    Jennifer Viegas
    Proceedings of the National Academy of Sciences Feb 2016, 113 (5) 1109-1111; DOI: 10.1073/pnas.1525099113
    Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Mendeley logo Mendeley
    Proceedings of the National Academy of Sciences: 113 (5)
    Table of Contents

    Submit

    Sign up for Article Alerts

    Jump to section

    • Article
      • Encouraged to Think About Biology
      • Foundations of Chemical Proteomics
      • Applying ABPP to Human Genetic Disorders
      • Extending ABPP to Metabolite-Binding Proteins
      • Endocannabinoid-Regulating Enzymes
      • Footnotes
      • References
    • Figures & SI
    • Info & Metrics
    • PDF

    You May Also be Interested in

    Abstract depiction of a guitar and musical note
    Science & Culture: At the nexus of music and medicine, some see disease treatments
    Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
    Image credit: Shutterstock/agsandrew.
    Scientist looking at an electronic tablet
    Opinion: Standardizing gene product nomenclature—a call to action
    Biomedical communities and journals need to standardize nomenclature of gene products to enhance accuracy in scientific and public communication.
    Image credit: Shutterstock/greenbutterfly.
    One red and one yellow modeled protein structures
    Journal Club: Study reveals evolutionary origins of fold-switching protein
    Shapeshifting designs could have wide-ranging pharmaceutical and biomedical applications in coming years.
    Image credit: Acacia Dishman/Medical College of Wisconsin.
    White and blue bird
    Hazards of ozone pollution to birds
    Amanda Rodewald, Ivan Rudik, and Catherine Kling talk about the hazards of ozone pollution to birds.
    Listen
    Past PodcastsSubscribe
    Goats standing in a pin
    Transplantation of sperm-producing stem cells
    CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
    Image credit: Jon M. Oatley.

    Similar Articles

    Site Logo
    Powered by HighWire
    • Submit Manuscript
    • Twitter
    • Facebook
    • RSS Feeds
    • Email Alerts

    Articles

    • Current Issue
    • Latest Articles
    • Archive

    PNAS Portals

    • Anthropology
    • Chemistry
    • Classics
    • Front Matter
    • Physics
    • Sustainability Science
    • Teaching Resources

    Information

    • Authors
    • Editorial Board
    • Reviewers
    • Librarians
    • Press
    • Site Map
    • PNAS Updates

    Feedback    Privacy/Legal

    Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490